Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Advice on Best ART Regimen for Patients Taking Cancer Therapy

Because no clinical trials address the question and published data are insufficient to support guidelines, the optimal antiretroviral therapy (ART) regimen for patients undergoing cancer chemotherapy remains unknown. But experts from Houston’s M.D. Anderson Cancer Center offer suggestions to help clinicians individualize therapy for each patient.

Published
25 June 2014
From
International AIDS Society
Mortality with HIV drops sharply in Georgia after 2004 cART rollout

Mortality among Georgians with HIV fell by more than half after 2004, when the Eastern European country began providing combination antiretroviral therapy (cART) to everyone in need. Tuberculosis remains a leading cause of death.

Published
23 June 2014
From
International AIDS Society
ART soon after birth for HIV-infected babies can achieve sustained viral suppression and reduce pool of HIV-infected cells

Antiretroviral therapy started soon after birth can suppress HIV to extremely low levels and severely restrict the size of the reservoir of HIV-infected cells in peripheral blood, Canadian

Published
19 June 2014
By
Michael Carter
HIV Cure: Babies' Lack of Memory T-Cells Make Virus Unable to Hide from drugs

The National Institutes of Health intends to launch a clinical trial for more than 400 HIV-infected infants to undergo strong antiretroviral drug therapy, inspired by the Mississippi baby who is now age 4 and likely cured from AIDS.

Published
19 June 2014
From
International Business Times
Dolutegravir in HIV-1 infection: Added benefit in adult patients

The German Institute for Quality and Efficiency in Health Care (IQWiG) has determined that the new integrase inhibitor drug dolutegravir (Tivicay ®) is of considerable added benefit to treatment-naive patients in comparison with current first-line therapies, and some added benefit to patients who already need to take an integrase inhibitor.

Published
19 June 2014
From
Science Daily
The Man Who Was Immune to AIDS - But Not What Came After

A profile of Steve Crohn, who committed suicide in 2013. Crohn was discovered to be immune to HIV infection due to the CCR5 delta 32 polymorphism. The profile examines questions how survivor guilt and ageing in the New York gay community may have contributed to his suicide.

Published
18 June 2014
From
New York magazine
New global clinical trial aims to replicate the mysterious “Mississippi baby” success

Researchers plan to identify 54 HIV-positive infants and treat them with standard antiretroviral drugs, beginning treatment within 48 hours of birth. The team plans to enroll HIV-positive infants across 17 hospitals and clinics in the U.S. and 11 other countries, including Haiti, India, Malawi, South Africa and Thailand.

Published
18 June 2014
From
Scientific American
South Africa: Antiretrovirals Credited for TB Decline

South Africa is seeing about 79,000 fewer TB cases annually thanks to increased HIV treatment uptake, according to the latest research from the National Institute for Communicable Diseases (NCID)

Published
13 June 2014
From
Health-e
Glaxo's ViiV Joins J&J's Janssen to Develop Single-Pill HIV Drug

Glaxo’s majority-owned ViiV Healthcare venture is collaborating with Johnson & Johnson’s Janssen unit to test a pill combining ViiV’s Tivicay with Janssen’s Edurant, ViiV said today in a statement. Trials are expected to begin next year, the Brentford, U.K.-based company said.

Published
13 June 2014
From
Bloomberg
PrEP users say it provides an 'extra layer of protection' and 'peace of mind'

American gay men who have chosen to take pre-exposure prophylaxis (PrEP) are aware of their own risk of being exposed to HIV and see PrEP as providing

Published
12 June 2014
By
Roger Pebody

Filter by country